Atomo have non-exclusive rights to market and distribute Access Bio’s rapid antigen test (Atomo didn’t develop it) - the test has 88.4% sensitivity and is FDA and TGA approved.
Ann: AnteoTech Progresses COVID-19 Test Toward Market Launch, page-524
-
- There are more pages in this discussion • 437 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.79M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 2.0¢ | $3.965K | 195.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1417631 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 95237 | 1 |
View Market Depth
| Last trade - 14.20pm 11/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |